The Sputnik-5 vaccine is being developed on the model of the Ebola vaccine.
Moscow. Alexander Gainsbourg, director of the Gamalaya National Research Center for Epidemiology and Microbiology and lead developer of the Sputnik-5 vaccine, says the vaccine is likely to provide protection against Kovid-19 for up to two years. “I can only make suggestions at the moment as more experimental data is needed. Our vaccine is being created on the model of the Ebola vaccine,” Tas news agency said on Saturday, citing in its statement on Saturday. the Soloviev live channel on YouTube. East.”
He added: “Of all the experiments that have been done so far, the data shows that this vaccine will provide protection for two years or more.”
According to this Russian scientist, Sputnik-5 was effective in 96% of cases. The remaining four percent of people vaccinated will have a runny nose, cough, and mild fever, but the lungs will not be affected.